Analysis of clinical manifestations, mutant gene and encoded protein in two Chinese MYH9-related disease families

Clinica Chimica Acta

Volumn 373, Issue 1-2, 2006, Pages 49-54

  Yi, Yan ^a   Sen Zhang, Guang ^a   Xu, Min ^a   San Ling, Zhu ^a   Ru Shao, Xiu ^b   Zeng Li, Jia ^b   Ma, Jun ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Haerbin Institute of Haematology and Oncology   (China)

Author keywords

Infection associated inclusion; MYH9 related disease; MYH9 related disease inclusion; Nonmuscle myosin heavy chain 9 gene; Nonmuscle myosin heavy chain IIA

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; IMMUNOGLOBULIN; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN 9; MYOSIN IIA; RESTRICTION ENDONUCLEASE; UNCLASSIFIED DRUG; YELLOW FLUORESCENT PROTEIN;

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BLEEDING TENDENCY; CASE REPORT; CHINESE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DATA ANALYSIS; DNA SEQUENCE; DRUG MEGADOSE; EPISTAXIS; FAMILIAL DISEASE; FAMILY; FEMALE; GENE EXPRESSION; GENE MUTATION; GIEMSA STAIN; HEMATOLOGIC DISEASE; HEMODIALYSIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; KIDNEY FAILURE; KIDNEY INJURY; MALE; MUTATIONAL ANALYSIS; MYOSIN HEAVY CHAIN 9 RELATED DISEASE; NEUTROPHIL; PETECHIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION MAPPING; SKIN MANIFESTATION; THROMBOCYTE; UPREGULATION; WESTERN BLOTTING;

ADULT; BLOOD PLATELETS; BLOTTING, WESTERN; CHINA; DNA MUTATIONAL ANALYSIS; EXONS; FAMILY HEALTH; FEMALE; HUMANS; MALE; MOLECULAR MOTOR PROTEINS; MYOSIN HEAVY CHAINS; NEUTROPHILS; PEDIGREE; PHENOTYPE; POINT MUTATION; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UP-REGULATION;

EID: 33747877118     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.04.027     Document Type: Article

References (16)

1. May R. Leukozyteneinschlusse. Dtsch Arch Klin Med 96 (1909) 1-6
2. Noris P., Spedini P., Belletti S., et al. Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly): clinical and laboratory findings. Am J Med 104 (1998) 355-360
3. Kunishima S., Kojima T., Tanaka T., et al. Mapping of a gene for May-Hegglin anomaly to chromosome 22q. Hum Genet 105 (1999) 379-383
4. Martignetti J.A., Heath K.E., Harris J., et al. The gene for May-Hegglin anomaly localizes to a < 1-Mb region on chromosome 22q12.3-13.1. Am J Hum Genet 66 (2000) 1449-1454
5. Kelley M.J., Jawien W., Lin A., et al. Autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly) is linked to chromosome 22q12-13. Hum Genet 106 (2000) 557-564
6. Toothaker L.E., Gonzalez D.A., Tung N., et al. Cellular myosin heavy chain in human leukocytes: isolation upregulation during myeloid differentiation. Blood 78 (1991) 1826-1833
7. Sellers J.R. Myosins: a diverse superfamily. Biochim Biophys Acta 1496 (2000) 3-22
8. Kunishima S., Matsushita T., Kojima T., et al. Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombcytopenia with leukocyte inclusions. J Hum Genet 46 (2001) 722-729
9. Heath K.E., Campos-Barros A., Toren A., et al. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. Am J Hum Genet 69 (2001) 1033-1045
10. Kunishima S., Kojima T., Matsushita T., et al. Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/Sebastian syndrome). Blood 15 97 (2001) 1147-1149
11. Pecci A., Noris P., Invernizzi R., et al. Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders. Br J Haematol 117 (2002) 164-167
12. Kelley M.J., Jawien W., Ortel T.L., et al. Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly. Nat Genet 26 (2000) 106-108
13. Seri M., Cusano R., Gangarossa S., et al. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium. Nat Genet 26 (2000) 103-105
14. Seri M., Pecci A., Bari F.D., et al. MYH9-related disease May-Hegglin anomaly, Sebastian Syndrome, Fetcher Syndrome, and Epstein Syndrome are not distinct entities but represent a variable expression of a single illness. Medicine 82 (2003) 203-215
15. Kunishima S., Matsushita T., Kojima T., et al. Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders: association of subcellular localization with MYH9 mutations. Lab Invest 83 (2003) 115-122
16. Deutsch S., Rideau A., Bochaton-Piallat M.L., et al. Asp1424Asn MYH9 mutation results in an unstable protein responsible for the phenotypes in May-Hegglin anomaly/Fechtner syndrome. Blood 102 (2003) 529-534